Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program

Breast Cancer Research and Treatment

Volumn 135, Issue 1, 2012, Pages 291-299

  Hofvind, Solveig ^a,b   Lee, Christoph I ^c   Elmore, Joann G ^d,e  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b OSLO METROPOLITAN UNIVERSITY   (Norway)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Breast cancer; Cancer incidence; Mastectomy rate; Population screening; Screening mammography; Stage specific incidence

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER SCREENING; CANCER SIZE; CANCER STAGING; EARLY CANCER; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; NORWAY; SURVIVAL RATE;

EID: 84865118947     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2162-x     Document Type: Article

References (29)

1. Vainio H, Bianchini F (eds) (2002) IARC handbook of cancer prevention Volume 7 Breast Cancer Screening. IARCPress, Lyon. http://www.iarc.fr. Accessed December 7, 2011
2. Food and Drug Administration (1997) Quality Mammography Standards. Final Rules-21 CRF Parts 16 and 900 (docket No. 95N-0192) RIN 0910-AA24 edition. 2011. Department of Health and Human Services, Washington, DC, pp 55925-55926
3. Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement (2009). Ann Intern Med 151:716-236
4. Duffy SW, Tabar L, Olsen AH et al (2010) Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen 17:25-30
5. Jorgensen KJ, Klahn A, Gotzsche PC (2007) Are benefits and harms in mammography screening given equal attention in scientific articles? A cross-sectional study. BMC Med 5:12 (Pubitemid 47018679)
6. Zahl PH, Gotzsche PC, Maehlen J (2011) Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study. Lancet Oncol 12:1118-1124
7. Kalager M, Zelen M, Langmark F, Adami HO (2010) Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med 363:1203-1210
8. Tabar L, Vitak B, Chen TH et al (2011) Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 260:658-663
9. Autier P, Boniol M, Gavin A, Vatten L (2011) Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ 343:d4411. doi: 10.1136/bmj.d441
10. Olsen AH, Njor SH, Lynge E (2007) Estimating the benefits of mammography screening: the impact of study design. Epidemiology 18:487-492 (Pubitemid 46955316)
11. Paap E, Holland R, den Heeten GJ et al (2010) A remarkable reduction of breast cancer deaths in screened versus unscreened women: a case-referent study. Cancer Causes Control 21:1569-1573
12. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE (2002) Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 359:909-919 (Pubitemid 34246378)
13. Tabar L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW (2003) Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 361:1405-1410 (Pubitemid 36515039)
14. Gotzsche PC, Nielsen M (2011) Screening for breast cancer with mammography. Cochrane Database Syst Rev CD001877
15. Swedish Organised Service Screening Evaluation Group (2006) Reduction in breast cancer mortality from the organised service screening with mammography: 2. Validation with alternative analytic methods. Cancer Epidemiol Biomarkers Prev 15:52-56
16. Swedish Organised Service Screening Evaluation Group (2006) Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev 15:45-51
17. Kalager M, Haldorsen T, Bretthauer M, Hoff G, Thoresen SO, Adami HO (2009) Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study. Breast Cancer Res 11:R44
18. Elmore JG, Nakano CY, Koepsell TD, Desnick LM, D'Orsi CJ, Ransohoff DF (2003) International variation in screening mammography interpretations in community-based programs. J Natl Cancer Inst 95(18):1384-1393 (Pubitemid 37220458)
19. Smith-Bindman R, Chu PW, Miglioretti DL et al (2003) Comparison of screening mammography in the United States and the United Kingdom. JAMA 290(16):2129-2137 (Pubitemid 37432973)
20. Hofvind S, Geller B, Vacek PM, Thoresen S, Skaane P (2007) Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program. Eur J Epidemiol 22:447-455 (Pubitemid 47222954)
21. Buiatti E, Barchielli A, Bartolacci S et al (2003) The impact of organised screening programmes on the stage-specific incidence of breast cancer in some Italian areas. Eur J Cancer 39:1776-1782 (Pubitemid 36897616)
22. Anderson WF, Jatoi I, Devesa SS (2006) Assessing the impact of screening mammography: breast cancer incidence and mortality rates in Connecticut (1943-2002). Breast Cancer Res Treat 99:333-340 (Pubitemid 44337926)
23. Norman SA, Localio AR, Zhou L et al (2006) Benefit of screening mammography in reducing the rate of late-stage breast cancer diagnoses (United States). Cancer Causes Control 17:921-929 (Pubitemid 44078283)
24. Larsen IK, Smastuen M, Johannesen TB et al (2009) Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 45:1218-1219
25. Regulations on the collection and processing of personal health data in the Cancer Registry of Norway (Cancer Registry Regulations). 2001. www.ub.uio.no/ujur/ulovdata/for-20011221-1477-eng.doc. Accessed January 24, 2011
26. Sobin LH, Gospodarowicz MK, Wittekind C (2010) TNM Classification of Malignant Tumours (UICC International Union Against Cancer), 7th edn. Wiley, Chichester
27. Perry N, Broeders MJ, de Wolf C, Holland R, von Karsa L (2006) European guidelines for quality assurance in breast cancer screening and diagnosis. 2006. Office for Official Publication of the European Communities, Luxembourg. European Communities. ISBN 92-79-01258-4
28. de Gelder R, Heijnsdijk EA, van Ravesteyn NT, Fracheboud J, Draisma G, de Koning HJ (2011) Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev 33:111-121
29. Lynge E, Braaten T, Njor SH et al (2011) Mammography activity in Norway 1983 to 2008. Acta Oncol 50:1062-1067